Companies: 10,795·Total market cap: $144.5T

Zai Lab Limited

Zai Lab Limited

ZLABNASDAQHealthcare● Active

$16.48

$-0.14(-0.84%)

Market Cap$1.9B

P/E Ratio—

52W High$44.34

52W Low$15.96

Avg Volume796K

Open$16.86

Beta0.78

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Zai Lab Limited（ZLAB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ZLAB · 截至 Jun 8, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Zai Lab Limited 数据

分析师预测$35 · Buy

股息不分红

分析师评级与目标价

Buy11 位分析师

Strong Buy

0

Buy

9

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$35.00Low

$16.48Current

$35.00Avg Target上涨空间 112.38%

$35.00High

合计: 11 · 买入占比: 81.8%

根据过去 3 个月内 11 位华尔街分析师，ZLAB 共识评级为 Buy，12 个月平均目标价 $35.00 （较现价 $16.48 上涨空间 112.38%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Zai Lab Limited

$16.48-0.84%$1.9B #2

Ascentage Pharma Group International

$17.12-0.47%$397.9M #3

Apogee Therapeutics, Inc.

$83.01-4.50%$5.1B #4

Cidara Therapeutics, Inc.

$221.38+0.00%$5.6B #5

Centessa Pharmaceuticals plc

$39.70+0.20%$6.1B #6

IDEAYA Biosciences, Inc.

$31.48+11.28%$2.8B

关于 Zai Lab Limited

CEOYing Du

IPO DateSep 20, 2017

Employees1,869

CountryCN

Websitezailaboratory.com

Zai Lab Limited Operating primarily in Mainland China and Hong Kong, Zai Lab Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medical treatments. Their…

Biotechnology HealthcareNASDAQADRCN

关于股票概览与关键数据

Zai Lab Limited（ZLAB）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 20, 2017 在 NASDAQ 上市。截至最近交易日，ZLAB 股价为 $16.48，市值约为 $1.9B。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Zai Lab Limited（ZLAB）股价为 $16.48，在 NASDAQ 上市，52周区间为 $15.96 – $44.34。

ZLAB 最新股价ZLAB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议